Armstrong Advisory Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$417K Buy
4,219
+4
+0.1% +$418 0.03% 156
2026
Q2
$383K Sell
4,215
-177
-4% -$16.2K 0.02% 182
2026
Q1
$451K Buy
4,392
+3
+0.1% +$339 0.03% 150
2025
Q4
$550K Buy
4,389
+483
+12% +$61.5K 0.04% 135
2025
Q3
$523K Buy
3,906
+3
+0.1% +$394 0.04% 129
2025
Q2
$531K Sell
3,903
-427
-10% -$56.3K 0.04% 117
2025
Q1
$490K Hold
4,330
– – 0.04% 111
2024
Q4
$490K Buy
4,330
+3
+0.1% +$347 0.04% 111
2024
Q3
$493K Sell
4,327
-30
-0.7% -$3.29K 0.04% 106
2024
Q2
$453K Sell
4,357
-279
-6% -$29.6K 0.04% 103
2024
Q1
$510K Hold
4,636
– – 0.05% 96
2023
Q4
$510K Buy
4,636
+3
+0.1% +$300 0.05% 96
2023
Q3
$449K Sell
4,633
-17
-0.4% -$1.78K 0.05% 93
2023
Q2
$507K Buy
4,650
+3
+0.1% +$320 0.05% 90
2023
Q1
$471K Sell
4,647
-253
-5% -$26.7K 0.06% 93
2022
Q4
$538K Buy
+4,900
New +$507K 0.07% 87

Other funds holding ABT

Armstrong Advisory Group's ABT Position: Q3 2026 in Review

Armstrong Advisory Group increased its Abbott (ABT) stake by 0.09% in Q3 2026, buying an estimated $418 and bringing the position to 4,219 shares worth $417K. The position accounts for 0.03% of the portfolio, ranked #156.

Armstrong Advisory Group first reported a position in ABT in Q4 2022 and has held it in 16 quarters since. The position peaked at $550K in Q4 2025. 766 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • Armstrong Advisory Group held 4,219 shares of Abbott worth $417K as of Q3 2026.
  • Armstrong Advisory Group bought 4 Abbott shares in Q3 2026, an estimated $418.
  • Abbott made up 0.03% of Armstrong Advisory Group's portfolio in Q3 2026, its #156 holding.
  • Armstrong Advisory Group first reported a position in Abbott in Q4 2022 and has held it in 16 quarters since.
  • Armstrong Advisory Group's Abbott position peaked at $550K in Q4 2025.
  • 766 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.